Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animalsEric E. Swayze, and C. Frank Bennett, Andrew Siwkowski et al.|Nucleic Acids Research|2006Cited by 461
Comprehensive Structure–Activity Relationship of Triantennary<i>N</i>-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to HepatocytesThazha P. Prakash, Punit P. Seth, Guillermo Vasquez et al.|Journal of Medicinal Chemistry|2016Cited by 131
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A. Anderson, Punit P. Seth, Graeme C. Freestone et al.|Nucleic Acids Research|2021Cited by 129
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotidesMichael E. Østergaard, Punit P. Seth, Cheryl Li De Hoyos et al.|Nucleic Acids Research|2020Cited by 98
Efficient Synthesis and Biological Evaluation of 5′-GalNAc Conjugated Antisense OligonucleotidesMichael E. Østergaard, Punit P. Seth, Jinghua Yu et al.|Bioconjugate Chemistry|2015Cited by 81